San Diego based-Sorrento Therapeutics announced it had found an antibody that was capable of neutralizing SARS-CoV-2 virus infection.
The company said it was 100% effective.
However, there have been no animal or human trials, and experts warned against overreaction
The antibody if effective could eventually become part of Sorrento’s COVI-SHIELD, a planned cocktail using antibodies.
The new sent the stock climbing but it closed Monday at $6.50 after opening at $9.98.